Skip to content
Aristo Bio-Tech & Lifescience logo

Aristo Bio-Tech & Lifescience

ARISTO NSE
₹90.00 +4.00 (+4.65%)
View as Markdown
MCP
Close 4 Nov 2026 ₹90.00 −38.00 −29.7% 1Y
Start ₹128.00

Key Fundamentals

SMEFertilizers & AgrochemicalsChemicals

Price-based figures as of · TTM

ROCE
19.60%
Debt to Equity
0.80
EPS (TTM)
—
Book Value
₹64.79
Market Cap
—
P/E (TTM)
—
P/B
1.39
ROE
17.60%
Dividend Yield
0.70%
EBITDA
₹16.50 Cr
52W High
₹135.00
52W Low
₹74.30
Day Range
₹86.00 – ₹90.00
Volume
23,200

Peer Comparison

Commodities › Chemicals › Pesticides & Agrochemicals

Aristo Bio-Tech & Lifescience peer comparison
UPL
₹529.0022.09₹43,728 Cr1.281.16%5.64%10.10%₹52,804 Cr₹2,323 Cr
PI Industries
₹2,187.0028.48₹33,248 Cr2.950.69%11.20%15.00%₹6,516 Cr₹1,164 Cr
Sumitomo Chemical
₹328.1028.24₹15,980 Cr4.430.41%17.60%23.50%₹3,192 Cr₹581 Cr
Bayer CropScience
₹3,249.9019.95₹14,602 Cr4.924.57%23.70%29.10%₹5,595 Cr₹733 Cr
Sharda Cropchem
₹677.959.77₹6,015 Cr1.882.23%23.20%30.20%₹5,357 Cr₹626 Cr
Dhanuka Agritech
₹942.7515.83₹4,217 Cr2.500.21%18.50%23.80%₹1,953 Cr₹268 Cr
Rallis
₹189.6717.23₹3,734 Cr1.681.58%10.20%14.10%₹2,962 Cr₹214 Cr
Aristo Bio-Tech & Lifescience (this company)
₹90.00—₹59 Cr1.390.70%17.60%19.60%——
Median 8 companies₹603.4819.95₹10,309 Cr2.190.93%17.60%21.55%₹5,357 Cr₹626 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Key Insights

Strengths

1
  • Company has delivered good profit growth of 46.1% CAGR over last 5 years

No weaknesses listed

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1162
OscillatorsBearish360
Moving AveragesStrong Bearish802

Key readings

RSI (14)
42.73
Neutral
MACD (12,26,9)
−4.18
Bearish
SMA (50)
98.88
Bearish
SMA (200)
112.84
Bearish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
10Y+20.37%
5Y+16.86%
3Y+18.64%
1Y+14.47%

Net profit

Net profit growth by window
10YZero base
5Y+47.58%
3Y+20.51%
1Y+75.00%

Operating cash flow

Operating cash flow growth by window
10Y—
5Y+35.10%
3YTurned positive
1Y−10.00%

10Y: The statements do not go back far enough for this window.

Operating margin· change in pp

Operating margin growth by window
10Y+2.65 pp
5Y+2.00 pp
3Y+0.27 pp
1Y+1.57 pp

Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹159 Cr
Mar 2018₹271 Cr
Mar 2019₹202 Cr
Mar 2020₹201 Cr
Mar 2021₹167 Cr
Mar 2022₹166 Cr
Mar 2023₹218 Cr
Mar 2024₹245 Cr
Mar 2025₹318 Cr
Mar 2026₹364 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹2.00 Cr
Mar 2018₹4.00 Cr
Mar 2019₹3.00 Cr
Mar 2020₹1.00 Cr
Mar 2021₹1.00 Cr
Mar 2022₹1.00 Cr
Mar 2023₹4.00 Cr
Mar 2024₹4.00 Cr
Mar 2025₹4.00 Cr
Mar 2026₹7.00 Cr

Half-yearly Results

₹ Cr
ARISTO half-yearly results, ₹ crore
Particulars Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
73
129
89
133
112
214
104
256
107
Expenses
72
124
85
128
109
206
103
249
99
Operating Profit
1
5
4
5
3
8
1
8
8
OPM %
1.2%
3.9%
4.1%
4%
2.9%
3.8%
1.1%
3.1%
8%
Other Income
0
0
0
0
0
0
0
0
0
Interest
1
1
2
1
1
1
1
1
3
Depreciation
1
1
1
1
1
1
1
1
1
PBT
−1
4
1
4
2
6
−1
6
4
Tax %
−35%
28%
13%
28%
27%
25%
−18%
25%
27%
Net Profit
0
3
1
3
1
5
0
4
3
EPS (₹)
−0.48
3.8
1.47
3.78
1.94
6.68
−0.72
6.13
4.42

Profit & Loss

₹ Cr
ARISTO profit and loss, annual, ₹ crore
Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
57
159
271
202
201
167
166
218
245
318
364
Expenses
56
157
263
195
197
163
160
209
236
309
348
Operating Profit
1
3
7
7
5
4
5
9
8
9
16
OPM %
1.6%
1.6%
2.7%
3.4%
2.2%
2.6%
3.3%
4%
3.5%
2.9%
4.4%
Other Income
0
1
1
0
0
0
0
0
0
0
0
Interest
0
1
2
2
3
2
2
3
2
2
4
Depreciation
0
0
0
1
1
1
1
2
2
3
3
PBT
1
3
6
4
1
2
2
5
5
5
10
Tax %
33%
31%
34%
31%
28%
28%
28%
25%
28%
26%
26%
Net Profit
0
2
4
3
1
1
1
4
4
4
7
EPS (₹)
0.8
3.7
7.48
5.67
2.02
2.16
2.14
5.23
5.73
5.96
10.55
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
5%
7%
10%
6%

Balance Sheet

₹ Cr
ARISTO balance sheet, annual, ₹ crore
Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
1
1
1
5
5
5
5
7
7
7
7
Reserves
2
4
7
6
7
8
10
23
27
31
37
Borrowings
5
10
20
14
20
22
25
22
21
22
35
Other Liabilities
20
72
60
65
56
46
37
47
73
81
76
Total Liabilities
27
87
89
91
88
81
77
100
127
141
155
Fixed Assets
2
2
8
8
8
12
14
16
22
24
24
CWIP
0
0
0
1
3
0
0
1
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
Other Assets
25
85
81
81
77
69
63
83
106
117
131
Total Assets
27
87
89
91
88
81
77
100
127
141
155

Cash Flow

₹ Cr
ARISTO cash flow, annual, ₹ crore
Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
−4
1
8
1
2
7
−3
8
10
9
Investing
—
0
−5
−2
−2
−2
−3
−4
−7
−5
−3
Financing
—
4
4
−6
1
−1
−3
8
−2
−4
−4
Net Cash Flow
—
0
0
0
0
0
0
1
−1
0
2
Free Cash Flow
—
−4
0
6
−1
0
4
−7
1
5
6
CFO/EBITDA
—
−123
38
138
40
60
134
−17
106
123
71

Ratios

ARISTO financial ratios, annual
Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
92
121
65
77
88
72
73
75
86
65
55
Inventory Days
66
67
42
65
47
78
60
57
65
59
70
Days Payable
142
177
85
124
74
93
87
85
112
97
78
Cash Conversion Cycle
16
11
23
18
61
56
46
48
38
26
47
Working Capital Days
3
14
14
15
20
28
25
36
31
22
24
ROCE %
—
31%
34%
24%
14%
11%
12%
16%
13%
13%
20%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Aristo Bio-Tech & Lifescience insights

56 extracted metrics across FY16–FY26.

Shareholding Pattern

As of Sep 2026

  • Promoters 73.42%
  • Public 24.26%
  • Others 2.32%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Aristo Bio-Tech & Lifescience

What does Aristo Bio-Tech & Lifescience Ltd do?
Incorporated in 2005, Aristo Bio-Tech and Lifescience Ltd manufactures and supplies pesticides and agrochemicals
Where is Aristo Bio-Tech & Lifescience Ltd (ARISTO) listed?
Aristo Bio-Tech & Lifescience Ltd trades as ARISTO on the NSE.
Which sector does Aristo Bio-Tech & Lifescience Ltd belong to?
Aristo Bio-Tech & Lifescience Ltd is classified under the Chemicals sector, in the Pesticides & Agrochemicals industry.
What is the 52-week high and low of Aristo Bio-Tech & Lifescience Ltd?
Over the last 52 weeks Aristo Bio-Tech & Lifescience Ltd has traded between ₹74.3 and ₹135 as of 4 Nov 2026.
Does Aristo Bio-Tech & Lifescience Ltd pay dividends?
Aristo Bio-Tech & Lifescience Ltd has a dividend yield of 0.70%.
What is the Return on Equity (ROE) of Aristo Bio-Tech & Lifescience Ltd?
Aristo Bio-Tech & Lifescience Ltd reported a return on equity of 17.60%. Its debt-to-equity ratio is 0.80.

Company Information

Incorporated in 2005, Aristo Bio-Tech and Lifescience Ltd manufactures and supplies pesticides and agrochemicals

Website aristobiotech.com
Listed 30 Jan 2023
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/ARISTO.md for Aristo Bio-Tech & Lifescience Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Fertilizer & Agrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month